[
  {
    "ts": null,
    "headline": "Vertex reports long-term results for Casgevy in sickle cell and thalassaemia",
    "summary": "Across 100 patients in three Phase III studies, Casgevy showed lasting benefits.",
    "url": "https://finnhub.io/api/news?id=6aabe4c72d43e89fc4fbc84cc99617d435de514afd06922a3a1eaf56a4f6e51e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751649493,
      "headline": "Vertex reports long-term results for Casgevy in sickle cell and thalassaemia",
      "id": 135759461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Across 100 patients in three Phase III studies, Casgevy showed lasting benefits.",
      "url": "https://finnhub.io/api/news?id=6aabe4c72d43e89fc4fbc84cc99617d435de514afd06922a3a1eaf56a4f6e51e"
    }
  }
]